Vyth-Dreese F - Search Results

1

Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients.

Bins A, Mallo H, Sein J, van den Bogaard C, Nooijen W, Vyth-Dreese F, Nuijen B, de Gast GC, Haanen JB. Bins A, et al. J Immunother. 2007 Feb-Mar;30(2):234-9. doi: 10.1097/01.cji.0000211333.06762.47. J Immunother. 2007. PMID: 17471170 Clinical Trial.

2

Temozolomide followed by combined immunotherapy with GM-CSF, low-dose IL2 and IFN alpha in patients with metastatic melanoma.

de Gast GC, Batchelor D, Kersten MJ, Vyth-Dreese FA, Sein J, van de Kasteele WF, Nooijen WJ, Nieweg OE, de Waal MA, Boogerd W. de Gast GC, et al. Br J Cancer. 2003 Jan 27;88(2):175-80. doi: 10.1038/sj.bjc.6600717. Br J Cancer. 2003. PMID: 12610499 Free PMC article.

3

Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-alpha in patients with progressive metastatic renal cell carcinoma.

Verra N, Jansen R, Groenewegen G, Mallo H, Kersten MJ, Bex A, Vyth-Dreese FA, Sein J, van de Kasteele W, Nooijen WJ, de Waal M, Horenblas S, de Gast GC. Verra N, et al. Br J Cancer. 2003 May 6;88(9):1346-51. doi: 10.1038/sj.bjc.6600915. Br J Cancer. 2003. PMID: 12778059 Free PMC article. Clinical Trial.

4

Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy.

Verra N, de Jong D, Bex A, Batchelor D, Dellemijn T, Sein J, Nooijen W, Meinhardt W, Horenblas S, de Gast G, Vyth-Dreese F. Verra N, et al. Eur Urol. 2005 Sep;48(3):527-33. doi: 10.1016/j.eururo.2005.03.031. Epub 2005 Apr 11. Eur Urol. 2005. PMID: 16115526 Clinical Trial.

5

T-cell immune function in tumor, skin, and peripheral blood of advanced stage melanoma patients: implications for immunotherapy.

Tjin EP, Konijnenberg D, Krebbers G, Mallo H, Drijfhout JW, Franken KL, van der Horst CM, Bos JD, Nieweg OE, Kroon BB, Haanen JB, Melief CJ, Vyth-Dreese FA, Luiten RM. Tjin EP, et al. Among authors: vyth dreese fa. Clin Cancer Res. 2011 Sep 1;17(17):5736-47. doi: 10.1158/1078-0432.CCR-11-0230. Epub 2011 Jul 12. Clin Cancer Res. 2011. PMID: 21750202

6

Immune-escape markers in relation to clinical outcome of advanced melanoma patients following immunotherapy.

Tjin EP, Krebbers G, Meijlink KJ, van de Kasteele W, Rosenberg EH, Sanders J, Nederlof PM, van de Wiel BA, Haanen JB, Melief CJ, Vyth-Dreese FA, Luiten RM. Tjin EP, et al. Among authors: vyth dreese fa. Cancer Immunol Res. 2014 Jun;2(6):538-46. doi: 10.1158/2326-6066.CIR-13-0097. Epub 2014 Mar 10. Cancer Immunol Res. 2014. PMID: 24894091

7

Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma.

de Gast GC, Klümpen HJ, Vyth-Dreese FA, Kersten MJ, Verra NC, Sein J, Batchelor D, Nooijen WJ, Schornagel JH. de Gast GC, et al. Clin Cancer Res. 2000 Apr;6(4):1267-72. Clin Cancer Res. 2000. PMID: 10778950 Clinical Trial.

8

Reinfusion of autologous lymphocytes with granulocyte-macrophage colony-stimulating factor induces rapid recovery of CD4+ and CD8+ T cells after high-dose chemotherapy for metastatic breast cancer.

de Gast GC, Vyth-Dreese FA, Nooijen W, van den Bogaard CJ, Sein J, Holtkamp MM, Linthorst GA, Baars JW, Schornagel JH, Rodenhuis S. de Gast GC, et al. J Clin Oncol. 2002 Jan 1;20(1):58-64. doi: 10.1200/JCO.2002.20.1.58. J Clin Oncol. 2002. PMID: 11773154 Clinical Trial.

9

In situ visualization of antigen-specific T cells in cryopreserved human tissues.

Vyth-Dreese FA, Kim YH, Dellemijn TA, Schrama E, Haanen JB, Spierings E, Goulmy E. Vyth-Dreese FA, et al. J Immunol Methods. 2006 Mar 20;310(1-2):78-85. doi: 10.1016/j.jim.2005.12.011. Epub 2006 Feb 2. J Immunol Methods. 2006. PMID: 16487538

10

Cytokine therapy response as a selection criterion for cytoreductive nephrectomy in metastatic renal clear-cell carcinoma of intermediate prognosis. Results and conclusions from a combined analysis.

Bex A, Haanen JB, Vyth-Dreese FA, Horenblas S, de Gast GC. Bex A, et al. Urol Int. 2008;80(4):367-71. doi: 10.1159/000132693. Epub 2008 Jun 27. Urol Int. 2008. PMID: 18587246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55 results

Search Page

Filters